PLK1 and neoplasm: By integrating siRNAs targeting polo-like kinase 1 (PLK1) and vascular endothelial growth factor receptor-2 (VEGF2), the Ang-3I-NM@siRNA effectively suppressed the GBM tumor growth (Fig. 11g).